109 related articles for article (PubMed ID: 34848459)
1. Evaluation of Erastin as a Therapeutic Agent Under Hypoxic Conditions in Pancreatic Cancer Cells.
Owada S; Endo H; Shida Y; Kinoue T; Furuya H; Tatemichi M
Anticancer Res; 2021 Dec; 41(12):6051-6059. PubMed ID: 34848459
[TBL] [Abstract][Full Text] [Related]
2. Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer.
Owada S; Endo H; Okada C; Yoshida K; Shida Y; Tatemichi M
Anticancer Res; 2020 Sep; 40(9):5071-5079. PubMed ID: 32878795
[TBL] [Abstract][Full Text] [Related]
3. Erastin induces apoptotic and ferroptotic cell death by inducing ROS accumulation by causing mitochondrial dysfunction in gastric cancer cell HGC‑27.
Sun Y; Deng R; Zhang C
Mol Med Rep; 2020 Oct; 22(4):2826-2832. PubMed ID: 32945484
[TBL] [Abstract][Full Text] [Related]
4. An Adaptation System to Avoid Apoptosis
Owada S; Ito K; Endo H; Shida Y; Okada C; Nezu T; Tatemichi M
Anticancer Res; 2017 Sep; 37(9):4927-4934. PubMed ID: 28870914
[TBL] [Abstract][Full Text] [Related]
5. Upregulation and activation of p53 by erastin‑induced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells.
Huang C; Yang M; Deng J; Li P; Su W; Jiang R
Oncol Rep; 2018 Oct; 40(4):2363-2370. PubMed ID: 30066882
[TBL] [Abstract][Full Text] [Related]
6. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
[TBL] [Abstract][Full Text] [Related]
7. Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells.
Li Y; Wang X; Chen YH; Tan QQ; Liu XB; Tan C
Anticancer Drugs; 2024 Mar; 35(3):227-236. PubMed ID: 38085677
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.
Geng N; Shi BJ; Li SL; Zhong ZY; Li YC; Xua WL; Zhou H; Cai JH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3826-3836. PubMed ID: 29949159
[TBL] [Abstract][Full Text] [Related]
9. In vitro hypoxic cytotoxicity and hypoxic radiosensitization. Efficacy of the novel 2-nitroimidazole N,N,N-tris[2-(2-nitro-1H-imidazol-1-yl)ethyl]amine.
Langenbacher M; Abdel-Jalil RJ; Voelter W; Weinmann M; Huber SM
Strahlenther Onkol; 2013 Mar; 189(3):246-54. PubMed ID: 23361139
[TBL] [Abstract][Full Text] [Related]
10. Simulating hypoxia-induced acidic environment in cancer cells facilitates mobilization and redox-cycling of genomic copper by daidzein leading to pro-oxidant cell death: implications for the sensitization of resistant hypoxic cancer cells to therapeutic challenges.
Ullah MF; Ahmad A; Bhat SH; Khan HY; Zubair H; Sarkar FH; Hadi SM
Biometals; 2016 Apr; 29(2):299-310. PubMed ID: 26872803
[TBL] [Abstract][Full Text] [Related]
11. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
[TBL] [Abstract][Full Text] [Related]
12. Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic.
Ohman KA; Hashim YM; Vangveravong S; Nywening TM; Cullinan DR; Goedegebuure SP; Liu J; Van Tine BA; Tiriac H; Tuveson DA; DeNardo DG; Spitzer D; Mach RH; Hawkins WG
Oncotarget; 2016 Jun; 7(23):33529-41. PubMed ID: 27244881
[TBL] [Abstract][Full Text] [Related]
13. Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.
Pati ML; Hornick JR; Niso M; Berardi F; Spitzer D; Abate C; Hawkins W
BMC Cancer; 2017 Jan; 17(1):51. PubMed ID: 28086830
[TBL] [Abstract][Full Text] [Related]
14. Protective roles of NRF2 signaling pathway in cobalt chloride-induced hypoxic cytotoxicity in human HaCaT keratinocytes.
Yang B; Cheng H; Wang L; Fu J; Zhang G; Guan D; Qi R; Gao X; Zhao R
Toxicol Appl Pharmacol; 2018 Sep; 355():189-197. PubMed ID: 29966676
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Li W; Cao L; Chen X; Lei J; Ma Q
Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia enhances antitumor activity of dichloroacetate.
Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
[TBL] [Abstract][Full Text] [Related]
17. Cobalt chloride treatment induces autophagic apoptosis in human glioma cells via a p53-dependent pathway.
Cheng BC; Chen JT; Yang ST; Chio CC; Liu SH; Chen RM
Int J Oncol; 2017 Mar; 50(3):964-974. PubMed ID: 28197638
[TBL] [Abstract][Full Text] [Related]
18. New method for the detection of reactive oxygen species in anti-tumoural activity of adriamycin: a comparison between hypoxic and normoxic cells.
Rharass T; Vigo J; Salmon JM; Ribou AC
Free Radic Res; 2008 Feb; 42(2):124-34. PubMed ID: 18297605
[TBL] [Abstract][Full Text] [Related]
19. 4-XL-PPD, a novel ginsenoside derivative, as potential therapeutic agents for gastric cancer shows anti-cancer activity via inducing cell apoptosis medicated generation of reactive oxygen species and inhibiting migratory and invasive.
Wang X; Sun YY; Qu FZ; Su GY; Zhao YQ
Biomed Pharmacother; 2019 Oct; 118():108589. PubMed ID: 31382131
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxia.
Magwere T; Burchill SA
PLoS One; 2011; 6(12):e28558. PubMed ID: 22174837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
